{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:06:32Z","timestamp":1777003592070,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00259-023-06286-1","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:01:48Z","timestamp":1686268908000},"page":"3251-3264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["[18F]DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-4666","authenticated-orcid":false,"given":"MA","family":"Peyronneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Kuhnast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D-L","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Jego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Sayet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Caill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lavisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Stankoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Remy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Bouilleret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bottlaender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"6286_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2008.01006.x","author":"M Cosenza-Nashat","year":"2009","unstructured":"Cosenza-Nashat M, Zhao ML, Suh HS, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol. 2009. https:\/\/doi.org\/10.1111\/j.1365-2990.2008.01006.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6286_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.08.006","author":"L Zhang","year":"2021","unstructured":"Zhang L, Hu K, Shao T, et al. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharm Sin B. 2021. https:\/\/doi.org\/10.1016\/j.apsb.2020.08.006.","journal-title":"Acta Pharm Sin B"},{"key":"6286_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy079","author":"L Hamelin","year":"2018","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G, et al. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer\u2019s disease. Brain. 2018. https:\/\/doi.org\/10.1093\/brain\/awy079.","journal-title":"Brain"},{"key":"6286_CR4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.231340","author":"B Bodini","year":"2020","unstructured":"Bodini B, Poirion E, Tonietto M, et al. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis. J Nucl Med. 2020. https:\/\/doi.org\/10.2967\/jnumed.119.231340.","journal-title":"J Nucl Med"},{"key":"6286_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.11.011","author":"S Lavisse","year":"2021","unstructured":"Lavisse S, Goutal S, Wimberley C, et al. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinsonism Relat Disord. 2021. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.011.","journal-title":"Parkinsonism Relat Disord"},{"key":"6286_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/bf03164587","author":"K Hashimoto","year":"1989","unstructured":"Hashimoto K, Inoue O, Suzuki K, et al. Synthesis and evaluation of 11C-PK11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann Nucl Med. 1989. https:\/\/doi.org\/10.1007\/bf03164587.","journal-title":"Ann Nucl Med"},{"key":"6286_CR7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.058669","author":"F Chauveau","year":"2009","unstructured":"Chauveau F, Van Camp N, Doll\u00e9 F, et al. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med. 2009. https:\/\/doi.org\/10.2967\/jnumed.108.058669.","journal-title":"J Nucl Med"},{"key":"6286_CR8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.046151","author":"ML James","year":"2008","unstructured":"James ML, Fulton RR, Vercoullie J, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med. 2008. https:\/\/doi.org\/10.2967\/jnumed.107.046151.","journal-title":"J Nucl Med"},{"key":"6286_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2962-9","author":"S Lavisse","year":"2015","unstructured":"Lavisse S, Inoue K, Jan C, et al. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain. Eur J Nucl Med Mol Imaging. 2015. https:\/\/doi.org\/10.1007\/s00259-014-2962-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6286_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2011.10.012","author":"N Arlicot","year":"2012","unstructured":"Arlicot N, Vercouillie J, Ribeiro MJ, et al. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Nucl Med Biol. 2012. https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.10.012.","journal-title":"Nucl Med Biol"},{"key":"6286_CR11","doi-asserted-by":"publisher","unstructured":"Lavisse S, Garc\u00eda-Lorenzo D, Peyronneau MA et al. Optimized Quantification of Translocator Protein Radioligand 18F-DPA-714\u00a0Uptake in the Brain of Genotyped Healthy controls. J. Nucl. Med. 2015; https:\/\/doi.org\/10.2967\/jnumed.115.156083.","DOI":"10.2967\/jnumed.115.156083"},{"key":"6286_CR12","doi-asserted-by":"publisher","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G et al. Clinical IMABio3 team. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. Brain. 2016; https:\/\/doi.org\/10.1093\/brain\/aww017.","DOI":"10.1093\/brain\/aww017"},{"key":"6286_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00326","author":"A Yrondi","year":"2018","unstructured":"Yrondi A, Aouizerate B, El-Hage W, et al. Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study). Front Psychiatry. 2018. https:\/\/doi.org\/10.3389\/fpsyt.2018.00326.","journal-title":"Front Psychiatry"},{"key":"6286_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04662-4","author":"P Backhaus","year":"2020","unstructured":"Backhaus P, Roll W, Beuker C, et al. Initial experience with [18F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system. Eur J Nucl Med Mol Imaging. 2020. https:\/\/doi.org\/10.1007\/s00259-019-04662-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6286_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.147","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012. https:\/\/doi.org\/10.1038\/jcbfm.2011.147.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6286_CR16","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.046342","author":"MA Peyronneau","year":"2013","unstructured":"Peyronneau MA, Saba W, Goutal S, et al. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand. Drug Metab Dispos. 2013. https:\/\/doi.org\/10.1124\/dmd.112.046342.","journal-title":"Drug Metab Dispos"},{"key":"6286_CR17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.tm118.004144","author":"FP Guengerich","year":"2019","unstructured":"Guengerich FP. Cytochrome P450 research and The Journal of Biological Chemistry. J Biol Chem. 2019. https:\/\/doi.org\/10.1074\/jbc.tm118.004144.","journal-title":"J Biol Chem"},{"key":"6286_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbi.2021.05.025","volume":"96","author":"M Vicente-Rodr\u00edguez","year":"2021","unstructured":"Vicente-Rodr\u00edguez M, Singh N, Turkheimer F, et al. Resolving the cellular specificity of TSPO imaging in a rat model of peripherally-induced neuroinflammation. Brain Behav Immun. 2021;96:154\u201367. https:\/\/doi.org\/10.1016\/j.bbi.2021.05.025.","journal-title":"Brain Behav Immun"},{"key":"6286_CR19","doi-asserted-by":"publisher","first-page":"108048","DOI":"10.1016\/j.pharmthera.2021.108048","volume":"234","author":"TR Guilarte","year":"2022","unstructured":"Guilarte TR, Alexander N, Rodichkin AN, et al. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization. Pharmacology & Therapeutics. 2022;234:108048. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108048.","journal-title":"Pharmacology & Therapeutics"},{"key":"6286_CR20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/diagnostics12051161","volume":"12","author":"YHD Fang","year":"2022","unstructured":"Fang YHD, McConathy JE, Yacoubian TA, et al. Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method. Diagnostics. 2022;12:1161. https:\/\/doi.org\/10.3390\/diagnostics12051161.","journal-title":"Diagnostics"},{"key":"6286_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00259-021-05248-9","volume":"49","author":"C Wimberley","year":"2021","unstructured":"Wimberley C, Lavisse S, Hillmer A, et al. Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain. Eur J Nucl Med Mol Imaging. 2021;49:246\u201356. https:\/\/doi.org\/10.1007\/s00259-021-05248-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6286_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.10.015","author":"B Kuhnast","year":"2012","unstructured":"Kuhnast B, Damont A, Hinnen F, et al. [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106-selective radioligands for imaging TSPO 18 kDa with PET: automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls. Appl Radiat Isot. 2012. https:\/\/doi.org\/10.1016\/j.apradiso.2011.10.015.","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"6286_CR23","first-page":"125","volume":"28","author":"B Ma","year":"2000","unstructured":"Ma B, Prueksaritanont T, Lin JH. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 2000;28(2):125\u201330.","journal-title":"Drug Metab Dispos"},{"key":"6286_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/s1543-5946(04)90003-7","author":"DR Guay","year":"2004","unstructured":"Guay DR. Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia. Am J Geriatr Pharmacother. 2004. https:\/\/doi.org\/10.1016\/s1543-5946(04)90003-7.","journal-title":"Am J Geriatr Pharmacother"},{"key":"6286_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.7b01012","author":"IG Denisov","year":"2018","unstructured":"Denisov IG, Baylon JL, Grinkova YV, et al. Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4. Biochemistry. 2018. https:\/\/doi.org\/10.1021\/acs.biochem.7b01012.","journal-title":"Biochemistry"},{"key":"6286_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2514-5","author":"E S\u00f6nnerstam","year":"2018","unstructured":"S\u00f6nnerstam E, Sj\u00f6lander M, L\u00f6vheim H, et al. Clinically relevant drug-drug interactions among elderly people with dementia. Eur J Clin Pharmacol. 2018. https:\/\/doi.org\/10.1007\/s00228-018-2514-5.","journal-title":"Eur J Clin Pharmacol"},{"key":"6286_CR27","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2011.633177","author":"YH Choi","year":"2012","unstructured":"Choi YH, Lee MG. Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes. Xenobiotica. 2012. https:\/\/doi.org\/10.3109\/00498254.2011.633177.","journal-title":"Xenobiotica"},{"key":"6286_CR28","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.28.882","author":"K Nakamura","year":"2005","unstructured":"Nakamura K, Ariyoshi N, Iwatsubo T, et al. Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes. Biol Pharm Bull. 2005. https:\/\/doi.org\/10.1248\/bpb.28.882.","journal-title":"Biol Pharm Bull"},{"key":"6286_CR29","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241100-00003","author":"MW Jann","year":"2002","unstructured":"Jann MW, Shirley KL, Small GW. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin Pharmacokinet. 2002. https:\/\/doi.org\/10.2165\/00003088-200241100-00003.","journal-title":"Clin Pharmacokinet"},{"key":"6286_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050731","author":"P Taavitsainen","year":"2000","unstructured":"Taavitsainen P, Kiukaanniemi K, Pelkonen O. In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin-II receptor antagonists. Eur J Clin Pharmacol. 2000. https:\/\/doi.org\/10.1007\/s002280050731.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"6286_CR31","first-page":"1146","volume":"29","author":"V Subrahmanyam","year":"2001","unstructured":"Subrahmanyam V, Renwick AB, Walters DG, et al. Identification of cytochrome P450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab Dispos. 2001;29(8):1146\u201355.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"6286_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2165\/00003088-199834040-00002","volume":"34","author":"S Caccia","year":"1998","unstructured":"Caccia S. Metabolism of the newer antidepressants An overview of the pharmacological and pharmacokinetic implications. Clin Pharmacokinet. 1998;34(4):281\u2013302. https:\/\/doi.org\/10.2165\/00003088-199834040-00002.","journal-title":"Clin Pharmacokinet"},{"key":"6286_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-015-0118-4","author":"P Martin","year":"2016","unstructured":"Martin P, Gillen M, Millson D, et al. Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies. Drugs R D. 2016. https:\/\/doi.org\/10.1007\/s40268-015-0118-4.","journal-title":"Drugs R D"},{"key":"6286_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000155342.93489.fd","author":"JA Armijo","year":"2005","unstructured":"Armijo JA, Vega-Gil N, Shushtarian M, et al. 10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio: influence of age and concomitant antiepileptic drugs. Ther Drug Monit. 2005. https:\/\/doi.org\/10.1097\/01.ftd.0000155342.93489.fd.","journal-title":"Ther Drug Monit"},{"key":"6286_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030623","author":"WW Kam","year":"2012","unstructured":"Kam WW, Meikle SR, Zhou H, et al. The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0030623.","journal-title":"PLoS ONE"},{"key":"6286_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17742004","author":"G Rizzo","year":"2019","unstructured":"Rizzo G, Veronese M, Tonietto M, et al. Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities. J Cereb Blood Flow Metab. 2019. https:\/\/doi.org\/10.1177\/0271678X17742004.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6286_CR37","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50393","author":"R Wolbold","year":"2003","unstructured":"Wolbold R, Klein K, Burk O, et al. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology. 2003. https:\/\/doi.org\/10.1053\/jhep.2003.50393.","journal-title":"Hepatology"},{"key":"6286_CR38","doi-asserted-by":"publisher","unstructured":"Cotreau, M.M, von Moltke, L.L & Greenblatt, D.J. The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates.\u00a0Clin Pharmacokinet. 2005; https:\/\/doi.org\/10.2165\/00003088-200544010-00002.","DOI":"10.2165\/00003088-200544010-00002"},{"key":"6286_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.10.009","author":"P Wang","year":"2020","unstructured":"Wang P, Shao X, Bao Y, et al. Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. Acta Pharm Sin B. 2020. https:\/\/doi.org\/10.1016\/j.apsb.2019.10.009.","journal-title":"Acta Pharm Sin B"},{"key":"6286_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04403-7","author":"J Tuisku","year":"2019","unstructured":"Tuisku J, Plav\u00e9n-Sigray P, Gaiser EC, et al. Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study. Eur J Nucl Med Mol Imaging. 2019. https:\/\/doi.org\/10.1007\/s00259-019-04403-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6286_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1298-3","author":"J Hirvonen","year":"2010","unstructured":"Hirvonen J, Roivainen A, Virta J, et al. Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation. Eur J Nucl Med Mol Imaging. 2010. https:\/\/doi.org\/10.1007\/s00259-009-1298-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6286_CR42","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.207431","author":"CA Foss","year":"2018","unstructured":"Foss CA, Plyku D, Ordonez AA, et al. Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation. J Nucl Med. 2018. https:\/\/doi.org\/10.2967\/jnumed.117.207431.","journal-title":"J Nucl Med"},{"key":"6286_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0271-6","author":"M Sakata","year":"2017","unstructured":"Sakata M, Ishibashi K, Imai M, et al. Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers. Eur J Nucl Med Mol Imaging Res. 2017. https:\/\/doi.org\/10.1186\/s13550-017-0271-6.","journal-title":"Eur J Nucl Med Mol Imaging Res"},{"key":"6286_CR44","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.044842","author":"AK Brown","year":"2007","unstructured":"Brown AK, Fujita M, Fujimura Y, et al. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. J Nucl Med. 2007. https:\/\/doi.org\/10.2967\/jnumed.107.044842.","journal-title":"J Nucl Med"},{"key":"6286_CR45","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.068064","author":"Y Fujimura","year":"2010","unstructured":"Fujimura Y, Kimura Y, Sim\u00e9on FG, et al. Biodistribution and radiation dosimetry in humans of a new PET ligand, (18)F-PBR06, to image translocator protein (18 kDa). J Nucl Med. 2010. https:\/\/doi.org\/10.2967\/jnumed.109.068064.","journal-title":"J Nucl Med"},{"key":"6286_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2014.07.004","author":"AL Brody","year":"2014","unstructured":"Brody AL, Okita K, Shieh J, et al. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET\/CT in healthy human volunteers. Nucl Med Biol. 2014. https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.07.004.","journal-title":"Nucl Med Biol"},{"key":"6286_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.11.056","author":"WC Kreisl","year":"2010","unstructured":"Kreisl WC, Fujita M, Fujimura Y, et al. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage. 2010. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.11.056.","journal-title":"Neuroimage"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06286-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06286-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06286-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T07:02:47Z","timestamp":1695970967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06286-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6286"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06286-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"6 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}